Prandil Tablet 1 mg contains Repaglinide, an oral antihyperglycemic agent used in the management of type 2 diabetes mellitus. Repaglinide belongs to the class of medications known as meglitinides and works by stimulating the pancreas to release insulin, thereby helping control blood glucose levels after meals.
Prandil is specifically formulated to improve postprandial (after-meal) blood sugar spikes, a common challenge in type 2 diabetes management. Its rapid onset and short duration of action make it ideal for patients who require flexible dosing based on meal schedules, ensuring effective glycemic control without prolonged risk of hypoglycemia.
This medication is suitable for adults with type 2 diabetes whose blood sugar cannot be adequately controlled through diet and exercise alone. It may be used as monotherapy or in combination with other antidiabetic agents such as metformin or thiazolidinediones for enhanced blood glucose management.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Active Ingredient – Repaglinide 1 mg: Stimulates insulin release from pancreatic beta cells to lower blood glucose.
Rapid Onset of Action: Quickly controls postprandial blood sugar spikes.
Short-Acting Effect: Reduces the risk of prolonged hypoglycemia between meals.
Flexible Dosing: Can be adjusted according to meal timing for optimal glycemic control.
Oral Tablet Formulation: Convenient and easy-to-administer for daily therapy.
Prandil Tablet 1 mg is indicated for:
Management of type 2 diabetes mellitus in adults
Control of postprandial hyperglycemia
Adjunctive therapy in patients whose blood sugar is not adequately controlled by diet and exercise alone
Combination therapy with other oral antidiabetic agents for improved glycemic control
Repaglinide in Prandil Tablet works by:
Stimulating Insulin Secretion: Binds to ATP-sensitive potassium channels on pancreatic beta cells, leading to insulin release.
Postprandial Blood Sugar Control: Targets glucose spikes immediately after meals for better glycemic stability.
Short Duration of Action: Minimizes risk of hypoglycemia between meals compared to longer-acting sulfonylureas.
Complementary Therapy: Can be combined with other antidiabetic medications to achieve overall glucose control.
This targeted mechanism ensures effective reduction in blood sugar levels while providing flexibility in dosing.
Adults: 1 mg orally before each main meal, or as directed by a physician.
Dose adjustments may be necessary based on individual blood glucose levels, dietary intake, and concomitant antidiabetic therapy.
Skip the dose if a meal is missed to reduce the risk of hypoglycemia.
Follow the physician’s instructions carefully for optimal blood sugar management.
Monitor for signs of hypoglycemia, especially during dose adjustments or when skipping meals.
Use with caution in patients with liver or kidney impairment.
Inform your doctor about all medications to prevent drug interactions, particularly with other antidiabetic agents.
Pregnant or breastfeeding women should use Prandil only under medical supervision.
Store in a cool, dry place below 25°C, away from moisture and light, and keep out of reach of children.
Prandil Tablet 1 mg provides effective and flexible blood glucose control for adults with type 2 diabetes, helping manage postprandial hyperglycemia while reducing the risk of hypoglycemia and supporting overall metabolic health.
Login Or Registerto submit your questions to seller
No none asked to seller yet